1 / 23

Gnahoua Zoabli, P.Eng ., M.Eng ., Ph.D . Chief of biomedical engineering depertment

AN INTEGRATED APPROACH TO PRIORITIZE EFFECTIVE AND SAFE ALTERNATIVE INFUSION METHODS TO VOLUMETRIC INFUSION PUMPS AT CSSS DU LAC-DES-DEUX-MONTAGNES. Gnahoua Zoabli, P.Eng ., M.Eng ., Ph.D . Chief of biomedical engineering depertment CSSS Du Lac-Des-Deux-Montagnes www.zoabli.com.

ganit
Download Presentation

Gnahoua Zoabli, P.Eng ., M.Eng ., Ph.D . Chief of biomedical engineering depertment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. AN INTEGRATED APPROACH TO PRIORITIZE EFFECTIVE AND SAFE ALTERNATIVE INFUSION METHODS TO VOLUMETRIC INFUSION PUMPS AT CSSS DU LAC-DES-DEUX-MONTAGNES GnahouaZoabli, P.Eng., M.Eng., Ph.D. Chief of biomedical engineering depertment CSSS Du Lac-Des-Deux-Montagnes www.zoabli.com Collaborators Sylvain Marcil1, Liane Rouiller1, Nathalie Bigras1, Chantale Séguin1, Nancy Chabot1, France Granger1, Arielle Katia M. Bada2, and Lucie Dugré1 1CSSS du Lac-des-Deux-Montagnes; 2École Polytechnique de Montréal

  2. Overview • Summary of the problem • Methodology • Results • Discussion • Conclusion

  3. Service du génie biomédical moncsss.com • Développements en cours – Plan stratégique 2010-2015 • Agrandissement du Bloc endoscopique (C) • Agrandissement de l’ urgence(E) • 35 civières • 4 salles de choc • Nouvelle Unité d’ophtalmologie (A) • Médecine nucléaire (M) • Nouveau Centre de télénéphrologie (M) • Nouveau Centre d’hémato-oncologie (M) 361 lits de courte durée 74+192 lits en hébergement 2 316 employés, employées, 22 pharmaciens 257 médecins 180 bénévoles

  4. Problematic • Issues regarding current models of volumetric pumps - software francization of their new model - compliance to Health Canada - availability estimated in 2015 (no replacement, no new purchase)

  5. Objective Find a contingency plan allowing CSSS LDDM to maintain an optimal intravenous therapy care to patients during this period.

  6. Methodology

  7. Methodology (Cont’d)

  8. Some illustrations

  9. Consultation of the medication administration guide The medication administration guide is developed by the pharmacy to associate each drug to be administered by IV to the suitable infusion technique. Name Administration mode Side Effects

  10. Medication Survey questionnaire/ Unit Recommended mode is not Volumetric pump Actually used with Volumetric pump ? How often ? Mini-infusion pump is recommended

  11. results

  12. Inventory of the volumetric pumps May 21, 2013 from 2:00 PM to 2:30 PM 27 volumetric pumps missing

  13. Our current practice in IV therapy Drugs administered by Volumetric pumps are mainly used in critical care units.

  14. IV Technology SelectionDecision Tree • In collaboration with the managers of medical care units and pharmacy, a decision tree has been developed • Objective: To determine the recommended infusion technology

  15. Weighted Pump/Medication ratio

  16. Weighted Pump/Medication ratio

  17. Discussion

  18. Main reasons of Volumetric pumps overuse

  19. Additional needs for Volumetric pumps(April 1, 2014) May 21, 2013

  20. Conclusion

  21. Acknowledgments • We thank the following members of the multidisciplinary team and managers whose involvement has led to develop the decision tree for IV therapy at CSSS LDDM. • Medical units • Michelle Dufour, Jacob Lalanne, and Nathalie Comtois • Surgery • MélissaPagé, and Jocelyne Sanscartier • Counselors in nursing • Chantal Laperriere, and DanyMaheux. • Their contribution has helped make more realistic the application of this IV therapy decision tree, facilitating thus its clinical acceptability.

  22. Questions ?

More Related